The Endocrine Society (endocrinologists) recently issued new guidelines for treatment of osteoporosis. These guidelines are a little bit more specific than recent guidelines from the American College of Physicians (internists), but both sets come in response to concerns from bone experts that physicians should be more aggressive in treating osteoporosis in order to prevent patients from suffering fractures.
Read all about it here: americanbonehealth.org/bone...
Here are two recommendations that might be of particular interest on this forum:
- Women who have been on the osteoporosis medicines called bisphosphonates for 3 to 5 years should get a repeat bone density test and fracture risk assessment. Women who have a low-to-moderate risk of fracture should be prescribed a “bisphosphonate holiday.”
- Patients at high risk should get a bone density test every 1 to 3 years.
What do you think of the new guidelines, based on your experience?